Literature DB >> 16402136

Family-based association study of Epsin 4 and Schizophrenia.

R Q Tang1, X Z Zhao, Y Y Shi, W Tang, N F Gu, G Y Feng, Y L Xing, S M Zhu, H Sang, P J Liang, L He.   

Abstract

Recently, Pimm et al. identified Epsin 4 on chromosome 5q33 as a susceptibility gene for schizophrenia in the British population, based on linkage and association evidence. In Pimm's case-control study, both the single polymorphisms and the individual haplotypes at the 5' end of the gene showed genetic association with schizophrenia. Here, we report the first study evaluating the relevance of Epsin 4 and schizophrenia outside the British population. Markers showing positive results in the original work as well as two additional polymorphisms were genotyped in 308 Han Chinese family trios. Transmission disequilibrium analysis was used to test for association of single-locus markers and multi-locus haplotypes with schizophrenia. Although no individual marker was significant at the P=0.05 level, the haplotypes detected in our samples, different from those previously reported, showed strong evidence of association (most significant global P=0.0021). Our results indicate the presence of a locus near the 5' end of Epsin 4 conferring susceptibility to the disease and provide further support for Epsin 4 as an important potential contributor to genetic risk in schizophrenia. Molecular Psychiatry (2006) 11, 395-399. doi:10.1038/sj.mp.4001780; published online 10 January 2006.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16402136     DOI: 10.1038/sj.mp.4001780

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  7 in total

1.  Analysis of protocadherin alpha gene enhancer polymorphism in bipolar disorder and schizophrenia.

Authors:  Erika Pedrosa; Radu Stefanescu; Benjamin Margolis; Oriana Petruolo; Yungtai Lo; Karen Nolan; Tomas Novak; Pavla Stopkova; Herbert M Lachman
Journal:  Schizophr Res       Date:  2008-05-27       Impact factor: 4.939

2.  Failure to confirm an association between Epsin 4 and schizophrenia in a Japanese population.

Authors:  Misty Richards; Yoshimi Iijima; Tomoko Shizuno; Yoko Kamegaya; Hiroaki Hori; Mayu Omori; Kunimasa Arima; Osamu Saitoh; Hiroshi Kunugi
Journal:  J Neural Transm (Vienna)       Date:  2008-08-12       Impact factor: 3.575

3.  Adaptive evolution of genes underlying schizophrenia.

Authors:  Bernard Crespi; Kyle Summers; Steve Dorus
Journal:  Proc Biol Sci       Date:  2007-11-22       Impact factor: 5.349

4.  A narrow and highly significant linkage signal for severe bipolar disorder in the chromosome 5q33 region in Latin American pedigrees.

Authors:  A J Jasinska; S Service; D Jawaheer; J DeYoung; M Levinson; Z Zhang; B Kremeyer; H Muller; I Aldana; J Garcia; G Restrepo; C Lopez; C Palacio; C Duque; M Parra; J Vega; D Ortiz; G Bedoya; C Mathews; P Davanzo; E Fournier; J Bejarano; M Ramirez; C Araya Ortiz; X Araya; J Molina; C Sabatti; V Reus; J Ospina; G Macaya; A Ruiz-Linares; N B Freimer
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-10-05       Impact factor: 3.568

5.  Segmental uniparental isodisomy on 5q32-qter in a patient with childhood-onset schizophrenia.

Authors:  J L Seal; M C Gornick; N Gogtay; P Shaw; D K Greenstein; M Coffey; P A Gochman; T Stromberg; Z Chen; B Merriman; S F Nelson; J Brooks; S Arepalli; F Wavrant-De Vrièze; J Hardy; J L Rapoport; A M Addington
Journal:  J Med Genet       Date:  2006-06-08       Impact factor: 6.318

6.  The effect of clozapine on mRNA expression for genes encoding G protein-coupled receptors and the protein components of clathrin-mediated endocytosis.

Authors:  Sally I Sharp; Ying Hu; Jon F Weymer; Mie Rizig; Andrew McQuillin; Stephen P Hunt; Hugh M D Gurling
Journal:  Psychiatr Genet       Date:  2013-08       Impact factor: 2.458

7.  Plasmolipin and Its Role in Cell Processes.

Authors:  A A Shulgin; T D Lebedev; V S Prassolov; P V Spirin
Journal:  Mol Biol       Date:  2021-12-17       Impact factor: 1.374

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.